- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有82家主力机构披露2025-06-30报告期持股数据，持仓量总计2.09亿股，占流通A股64.91%
- 波段诊断：
-
技术面诊股
诊断结果：4.4技术面打败了31%的股票
技术面评分前10的股票
近期的平均成本为42.27元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为42.27元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"42.27","date":1772440283,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑赢行业平均水平。
[{"date":"2026.03.03","stock":"-0.52","trade":"-2.99","ind":"-1.43"},{"date":"2026.03.02","stock":"-1.13","trade":"-2.61","ind":"0.47"},{"date":"2026.02.27","stock":"0.90","trade":"0.28","ind":"0.39"},{"date":"2026.02.26","stock":"-0.59","trade":"-0.72","ind":"-0.01"},{"date":"2026.02.25","stock":"1.51","trade":"1.27","ind":"0.72"},{"date":"2026.02.24","stock":"0.19","trade":"0.43","ind":"0.87"},{"date":"2026.02.13","stock":"-1.49","trade":"-0.55","ind":"-1.26"},{"date":"2026.02.12","stock":"-0.61","trade":"-0.47","ind":"0.05"},{"date":"2026.02.11","stock":"-0.42","trade":"-0.58","ind":"0.09"},{"date":"2026.02.10","stock":"0.23","trade":"0.30","ind":"0.13"},{"date":"2026.02.09","stock":"-0.14","trade":"0.78","ind":"1.41"},{"date":"2026.02.06","stock":"1.42","trade":"0.22","ind":"-0.25"},{"date":"2026.02.05","stock":"0.48","trade":"-0.38","ind":"-0.64"},{"date":"2026.02.04","stock":"0.17","trade":"0.70","ind":"0.85"},{"date":"2026.02.03","stock":"1.09","trade":"1.66","ind":"1.29"},{"date":"2026.02.02","stock":"-2.24","trade":"-2.66","ind":"-2.48"},{"date":"2026.01.30","stock":"-0.93","trade":"-1.26","ind":"-0.96"},{"date":"2026.01.29","stock":"0.28","trade":"-1.58","ind":"0.16"},{"date":"2026.01.28","stock":"-2.15","trade":"-2.31","ind":"0.27"},{"date":"2026.01.27","stock":"-2.15","trade":"-0.80","ind":"0.18"},{"date":"2026.01.26","stock":"1.43","trade":"3.60","ind":"-0.09"}]
西藏药业,上证指数,生物制品指数
压力支撑
该股压力位为42.18元，支撑位为41.62元。
[{"text":"\u538b\u529b\u4f4d","value":"42.18","date":1772467200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"41.62","date":1772467200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.0资金面打败了71%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：03月03日 20:31
| 机构今日流向(万元) | -2249.86 | 机构5日流向(万元) | -7048.48 |
| 机构10日流向(万元) | -12144.33 | 机构20日流向(万元) | -28846.35 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加220.93万股，其中基金净减仓19家，主力净增仓5家，请投资者中长期谨慎为宜。
截止2025-06-30，共82家主力机构（基金73家，一般法人7家，QFII1家，社保基金1家），持仓量总计20920.91万股，占流通A股64.91%
其中，基金持仓与2024-12-31相比：
增仓：7家 ，增持 54.97万股
减仓：26家 ，减持 44.90万股
新出现在主力名单中：34家 ，持有245.8万股
从主力名单中消失：29家 ，原持有27.92万股
其中，基金持仓与2024-12-31相比：
增仓：7家 ，增持 54.97万股
减仓：26家 ，减持 44.90万股
新出现在主力名单中：34家 ，持有245.8万股
从主力名单中消失：29家 ，原持有27.92万股
消息面诊股
诊断结果：5.5消息面打败了52%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 西藏药业：3月2日获融资买入916.93万元
2026-03-03 - 西藏药业：2月27日获融资买入497.00万元
2026-02-28 - 西藏药业：2月26日获融资买入777.53万元
2026-02-27 - 西藏药业：2月25日获融资买入978.76万元
2026-02-26 - 西藏药业：2月24日获融资买入944.88万元
2026-02-25 - 西藏药业启动股份回购计划，拟回购1.7亿至2亿元股
2026-02-14 - 西藏药业：2月13日获融资买入723.23万元
2026-02-14 - 西藏药业：2月12日获融资买入629.22万元
2026-02-13 - 西藏药业：2月11日获融资买入668.26万元
2026-02-12 - 西藏药业：2月10日获融资买入550.69万元
2026-02-11
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2026-02-06 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-02 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-28 |
| 利好 | 分红转增 | 10派8.810元(含税) | 2025-08-16 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-09 |
| 利好 | 分红转增 | 10派7.280元(含税) | 2025-03-15 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-15 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.0行业面打败了74%的股票
生物制品行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2026.03.03","price":"-1.43","value":"-2.99"},{"date":"2026.03.02","price":"0.47","value":"-2.61"},{"date":"2026.02.27","price":"0.39","value":"0.28"},{"date":"2026.02.26","price":"-0.01","value":"-0.72"},{"date":"2026.02.25","price":"0.72","value":"1.27"},{"date":"2026.02.24","price":"0.87","value":"0.43"},{"date":"2026.02.13","price":"-1.26","value":"-0.55"},{"date":"2026.02.12","price":"0.05","value":"-0.47"},{"date":"2026.02.11","price":"0.09","value":"-0.58"},{"date":"2026.02.10","price":"0.13","value":"0.30"},{"date":"2026.02.09","price":"1.41","value":"0.78"},{"date":"2026.02.06","price":"-0.25","value":"0.22"},{"date":"2026.02.05","price":"-0.64","value":"-0.38"},{"date":"2026.02.04","price":"0.85","value":"0.70"},{"date":"2026.02.03","price":"1.29","value":"1.66"},{"date":"2026.02.02","price":"-2.48","value":"-2.66"},{"date":"2026.01.30","price":"-0.96","value":"-1.26"},{"date":"2026.01.29","price":"0.16","value":"-1.58"},{"date":"2026.01.28","price":"0.27","value":"-2.31"},{"date":"2026.01.27","price":"0.18","value":"-0.80"},{"date":"2026.01.26","price":"-0.09","value":"3.60"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万泽股份 | 30.96% | -0.89% | 6.2分 |
| 2 | ST未名 | 13.67% | 10.27% | 5.1分 |
| 3 | 卫光生物 | 10.71% | -5.06% | 5.6分 |
| 4 | 诺诚健华 | 7.80% | -9.04% | 5.0分 |
| 5 | 欧林生物 | 3.16% | 2.53% | 5.4分 |
| 6 | 上海莱士 | -0.47% | 0.64% | 5.3分 |
| 8 | 三生国健 | -1.71% | -3.76% | 5.0分 |
| 10 | 特宝生物 | -2.31% | -1.15% | 4.9分 |
| 12 | *ST四环 | -4.21% | 3.80% | 5.7分 |
| 14 | - | -5.36% | -7.67% | 分 |
| 16 | 西藏药业 | -6.06% | 0.14% | 5.0分 |
| 18 | 博雅生物 | -7.64% | -3.47% | 4.5分 |
| 20 | 成大生物 | -7.89% | -2.66% | 4.2分 |
| 22 | 安科生物 | -8.76% | -4.82% | 4.5分 |
| 24 | 华兰生物 | -9.10% | -1.49% | 4.9分 |
| 26 | 赛升药业 | -10.01% | -7.86% | 4.2分 |
| 28 | 义翘神州 | -10.65% | -6.16% | 4.9分 |
| 30 | 凯因科技 | -10.74% | -6.36% | 4.2分 |
| 32 | 长春高新 | -11.63% | 1.71% | 4.3分 |
| 34 | 诺唯赞 | -12.41% | -6.04% | 4.2分 |
| 36 | 百克生物 | -12.97% | -5.09% | 3.8分 |
| 38 | 康泰生物 | -13.34% | -7.36% | 3.7分 |
| 40 | 禾元生物 | -13.90% | -1.99% | 4.4分 |
| 42 | 康华生物 | -16.24% | -10.46% | 4.2分 |
| 44 | 华兰疫苗 | -18.38% | -9.29% | 5.0分 |
| 46 | 神州细胞 | -19.35% | -6.33% | 3.9分 |
| 48 | 科兴制药 | -19.76% | -6.95% | 4.5分 |
| 50 | 君实生物 | -21.02% | -12.52% | 4.2分 |
| 52 | - | -21.19% | -8.00% | 分 |
| 54 | 金迪克 | -27.29% | -7.41% | 3.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 2/71 ， 4/71。
[{"date":"2025-09-30","value":"19.33","vol":"-9.78"},{"date":"2025-06-30","value":"14.04","vol":"-0.61"},{"date":"2025-03-31","value":"6.72","vol":"0.46"},{"date":"2024-12-31","value":"28.95","vol":"-0.68"},{"date":"2024-09-30","value":"22.71","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
19.33 | 14.04 | 6.72 | 28.95 | 22.71 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"93.73","vol":"67.61"},{"date":"2025-06-30","value":"94.60","vol":"68.28"},{"date":"2025-03-31","value":"94.76","vol":"68.43"},{"date":"2024-12-31","value":"94.22","vol":"69.85"},{"date":"2024-09-30","value":"94.93","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
93.73 | 94.60 | 94.76 | 94.22 | 94.93 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 36/71 ， 30/71。
[{"date":"2025-09-30","value":"-3.96","vol":"45.25"},{"date":"2025-06-30","value":"2.23","vol":"6902.04"},{"date":"2025-03-31","value":"1.12","vol":"6125.27"},{"date":"2024-12-31","value":"-10.45","vol":"47.35"},{"date":"2024-09-30","value":"-8.13","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-3.96 | 2.23 | 1.12 | -10.45 | -8.13 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-8.85","vol":"44.80"},{"date":"2025-06-30","value":"-8.96","vol":"5.44"},{"date":"2025-03-31","value":"-13.95","vol":"-8.46"},{"date":"2024-12-31","value":"31.26","vol":"-9.81"},{"date":"2024-09-30","value":"-7.42","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-8.85 | -8.96 | -13.95 | 31.26 | -7.42 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 3/71 ， 18/71。
[{"date":"2025-09-30","value":"0.40","vol":"0.22"},{"date":"2025-06-30","value":"0.32","vol":"0.14"},{"date":"2025-03-31","value":"0.14","vol":"0.06"},{"date":"2024-12-31","value":"0.60","vol":"0.29"},{"date":"2024-09-30","value":"0.47","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.40 | 0.32 | 0.14 | 0.60 | 0.47 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.85","vol":"0.92"},{"date":"2025-06-30","value":"0.63","vol":"0.56"},{"date":"2025-03-31","value":"0.26","vol":"0.26"},{"date":"2024-12-31","value":"1.32","vol":"1.17"},{"date":"2024-09-30","value":"0.89","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.85 | 0.63 | 0.26 | 1.32 | 0.89 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"25.73","vol":"1.84"},{"date":"2025-06-30","value":"30.94","vol":"-1377.61"},{"date":"2025-03-31","value":"43.51","vol":"-46.99"},{"date":"2024-12-31","value":"39.21","vol":"-11.33"},{"date":"2024-09-30","value":"27.20","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 25.73 | 30.94 | 43.51 | 39.21 | 27.20 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.25","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.50","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.25 | - | 0.50 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 16/71 ， 29/71。
[{"date":"2025-09-30","value":"3.02","vol":"6.00"},{"date":"2025-06-30","value":"2.94","vol":"6.64"},{"date":"2025-03-31","value":"3.86","vol":"7.75"},{"date":"2024-12-31","value":"4.66","vol":"6.72"},{"date":"2024-09-30","value":"3.58","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.02 | 2.94 | 3.86 | 4.66 | 3.58 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.83","vol":"4.84"},{"date":"2025-06-30","value":"2.78","vol":"5.30"},{"date":"2025-03-31","value":"3.66","vol":"6.35"},{"date":"2024-12-31","value":"4.40","vol":"5.40"},{"date":"2024-09-30","value":"3.34","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.83 | 2.78 | 3.66 | 4.40 | 3.34 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 16/71 ， 15/71。
[{"date":"2025-09-30","value":"32.25","vol":"28.18"},{"date":"2025-06-30","value":"25.88","vol":"26.73"},{"date":"2025-03-31","value":"20.79","vol":"26.03"},{"date":"2024-12-31","value":"16.75","vol":"25.81"},{"date":"2024-09-30","value":"21.57","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
32.25 | 25.88 | 20.79 | 16.75 | 21.57 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.53","vol":"0.58"},{"date":"2025-06-30","value":"0.35","vol":"1.11"},{"date":"2025-03-31","value":"0.26","vol":"0.78"},{"date":"2024-12-31","value":"0.20","vol":"0.87"},{"date":"2024-09-30","value":"0.28","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.53 | 0.35 | 0.26 | 0.20 | 0.28 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.09","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.70","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.01","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"10.51","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.37","blueLineValue":"2.91","type":"YC"}]